Search research articles
Contact Us
Filters
Showing results (161-170 of 401) with videos related to
Page
of 41
Sort By:
Thrombosis and Haemostasis
|
February 15, 2018
Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study
Robert F Storey, Diego Ardissino, Luigi Vignali, et al.
JAMA Cardiology
|
May 21, 2020
Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis
Kevin R Bainey, Thomas Engstrøm, Pieter C Smits, et al.
Thrombosis and Haemostasis
|
April 22, 2016
Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction
Mark R Thomas, Allison C Morton, Rashed Hossain, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 6, 2016
Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy
Evangelos Giannitsis, Lars Wallentin, Stefan K James, et al.
American Heart Journal
|
June 23, 2014
Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study
Axel Akerblom, Niclas Eriksson, Lars Wallentin, et al.
American Heart Journal
|
November 10, 2012
Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients -- results from the PLATelet inhibition and patient Outcomes (PLATO) study
Axel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.
Expert Review of Cardiovascular Therapy
|
July 1, 2024
Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation
Mark A Sammut, Dwayne Conway, Javaid Iqbal, et al.
Journal of Thrombosis and Thrombolysis
|
September 13, 2019
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Axel Åkerblom, Daniel Wojdyla, Philippe Gabriel Steg, et al.
Clinical Cardiology
|
August 8, 2021
Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi-country observational study
Eva Lesén, Christopher Hewitt, Evangelos Giannitsis, et al.
European Heart Journal. Acute Cardiovascular Care
|
December 24, 2019
Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel
Mark R Thomas, Stefan K James, Richard C Becker, et al.
Page
of 41
Search research articles
Search
Showing results (161-170 of 401) with videos related to
Sort By:
Page
of 41
Thrombosis and Haemostasis
|
February 15, 2018
Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study
Robert F Storey, Diego Ardissino, Luigi Vignali, et al.
JAMA Cardiology
|
May 21, 2020
Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis
Kevin R Bainey, Thomas Engstrøm, Pieter C Smits, et al.
Thrombosis and Haemostasis
|
April 22, 2016
Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction
Mark R Thomas, Allison C Morton, Rashed Hossain, et al.
European Heart Journal. Acute Cardiovascular Care
|
April 6, 2016
Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy
Evangelos Giannitsis, Lars Wallentin, Stefan K James, et al.
American Heart Journal
|
June 23, 2014
Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study
Axel Akerblom, Niclas Eriksson, Lars Wallentin, et al.
American Heart Journal
|
November 10, 2012
Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients -- results from the PLATelet inhibition and patient Outcomes (PLATO) study
Axel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.
Expert Review of Cardiovascular Therapy
|
July 1, 2024
Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation
Mark A Sammut, Dwayne Conway, Javaid Iqbal, et al.
Journal of Thrombosis and Thrombolysis
|
September 13, 2019
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Axel Åkerblom, Daniel Wojdyla, Philippe Gabriel Steg, et al.
Clinical Cardiology
|
August 8, 2021
Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi-country observational study
Eva Lesén, Christopher Hewitt, Evangelos Giannitsis, et al.
European Heart Journal. Acute Cardiovascular Care
|
December 24, 2019
Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel
Mark R Thomas, Stefan K James, Richard C Becker, et al.
Page
of 41